Cargando…
The adaptive transition of glioblastoma stem cells and its implications on treatments
Glioblastoma is the most malignant tumor occurring in the human central nervous system with overall median survival time <14.6 months. Current treatments such as chemotherapy and radiotherapy cannot reach an optimal remission since tumor resistance to therapy remains a challenge. Glioblastoma ste...
Autores principales: | Wang, Zeyu, Zhang, Hao, Xu, Shengchao, Liu, Zhixiong, Cheng, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985200/ https://www.ncbi.nlm.nih.gov/pubmed/33753720 http://dx.doi.org/10.1038/s41392-021-00491-w |
Ejemplares similares
-
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling
por: Xu, Shengchao, et al.
Publicado: (2023) -
Autophagy Modulation and Its Implications on Glioblastoma Treatment
por: Chen, Johnny, et al.
Publicado: (2023) -
Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications
por: Gürsel, Demirkan B., et al.
Publicado: (2011) -
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022) -
Correction: Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022)